Christine Baker
Directeur/Bestuurslid bij TuHURA Biopharma, Inc.
Vermogen: 13 023 $ op 30-04-2024
Profiel
Christine D.
Baker is a professional with a background in sales and marketing.
She is currently a Non-Executive Director at TuHURA Biopharma, Inc. Her former positions include Vice President-Sales & Marketing at Schering-Plough Corp., Vice President-Oncology at Novartis Corp., Chief Business Officer at EpicentRx, Inc., Chief Operating Officer at HOOKIPA Pharma, Inc., and Principal at Cd Baker Consulting LLC.
She holds an undergraduate degree from Dartmouth College and an MBA from Rutgers State University of New Jersey.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HOOKIPA PHARMA, INC.
0.02% | 22-04-2024 | 16 158 ( 0.02% ) | 13 023 $ | 30-04-2024 |
Actieve functies van Christine Baker
| Bedrijven | Functie | Begin |
|---|---|---|
TuHURA Biopharma, Inc.
 TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Christine Baker
| Bedrijven | Functie | Einde |
|---|---|---|
| HOOKIPA PHARMA INC. | Operationeel Directeur | 15-01-2024 |
| TYME TECHNOLOGIES, INC. | Directeur/Bestuurslid | 16-09-2022 |
EpicentRx, Inc.
 EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Corporate Officer/Principal | 01-01-2019 |
| Cd Baker Consulting LLC | Corporate Officer/Principal | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Verkoop & Marketing | - |
Opleiding van Christine Baker
| Dartmouth College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HOOKIPA PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
TuHURA Biopharma, Inc.
TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Cd Baker Consulting LLC | |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
